Stühler, Viktoria
Rausch, Steffen
Kroll, Katharina
Scharpf, Marcus
Stenzl, Arnulf
Bedke, Jens http://orcid.org/0000-0003-2778-3108
Funding for this research was provided by:
Eberhard Karls Universität Tübingen
Article History
Received: 9 November 2020
Accepted: 10 February 2021
First Online: 27 February 2021
Compliance with ethical standards
:
: Dr. Bedke reports Consultancies and Speaker’s Bureau: BMS; Eisai, EUSA, Ipsen, Novartis, MSD, Pfizer, Roche and study participation with institutional funding: Bayer, BMS; Eisai, Exelixis, Ipsen, Novartis, MSD, Pfizer, Roche. Dr. Stenzl reports Consultancies and Speaker’s Bureau: Ipsen, Roche, Janssen, BMS, Alere, Stebabiotech, Synergo, Ferring, Astellas, Amgen, Sanofi Aventis, CureVac and study participation or research grants with institutional funding: Johnson & Johnson, Roche, Cepheid, Amgen, Bayer, CureVac, GemeDx biotechnologies GmbH, Novartis, Karl Storz, immatics biotechnologies GmbH. All other authors declare no conflict of interest.
: The creation and retrospective review of our database was approved by the ethics committee of the University of Tuebingen, Germany, and, therefore, conforms to the ethical standards laid down in the 1964 Helsinki Declaration and its later amendments.
: Informed written consent was provided by each subject prior to surgical resection and the use of the tissue was approved by the ethics committee of the University of Tuebingen.